Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fishbane

Showing results (71-80 of 357) with videos related to

Pageof 36
Sort By:
Kidney International. Supplement|July 31, 2010
Anemia management in chronic kidney diseaseSteven Fishbane, Allen R Nissenson
Hemodialysis International. International Symposium on Home Hemodialysis|April 4, 2017
Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysisSteven Fishbane, Hitesh H Shah
The New England Journal of Medicine|July 2, 2020
Roxadustat for Anemia in Patients with Chronic Kidney DiseaseHitesh H Shah, Steven Fishbane
Seminars in Dialysis|June 9, 2007
CHOIR, CREATE, and anemia treatment in patients with CKDJeffrey S Berns, Steven Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1997
Iron management in end-stage renal diseaseS Fishbane, J K Maesaka
Seminars in Dialysis|July 7, 2018
Introduction to unresolved issues in the care of dialysis patientsAnna T Mathew, Steven Fishbane
Kidney International|June 20, 2008
Iron deficiency in non-dialysis chronic kidney diseaseSteven Fishbane, Ajay K Singh
Seminars in Dialysis|December 29, 2000
The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconateS Fishbane, E A Kowalski
Kidney International|August 18, 2005
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietinSteven Fishbane, Jeffrey S Berns
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1995
The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patientsS Fishbane, R I Lynn
Pageof 36

Showing results (71-80 of 357) with videos related to

Sort By:
Pageof 36
Kidney International. Supplement|July 31, 2010
Anemia management in chronic kidney diseaseSteven Fishbane, Allen R Nissenson
Hemodialysis International. International Symposium on Home Hemodialysis|April 4, 2017
Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysisSteven Fishbane, Hitesh H Shah
The New England Journal of Medicine|July 2, 2020
Roxadustat for Anemia in Patients with Chronic Kidney DiseaseHitesh H Shah, Steven Fishbane
Seminars in Dialysis|June 9, 2007
CHOIR, CREATE, and anemia treatment in patients with CKDJeffrey S Berns, Steven Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1997
Iron management in end-stage renal diseaseS Fishbane, J K Maesaka
Seminars in Dialysis|July 7, 2018
Introduction to unresolved issues in the care of dialysis patientsAnna T Mathew, Steven Fishbane
Kidney International|June 20, 2008
Iron deficiency in non-dialysis chronic kidney diseaseSteven Fishbane, Ajay K Singh
Seminars in Dialysis|December 29, 2000
The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconateS Fishbane, E A Kowalski
Kidney International|August 18, 2005
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietinSteven Fishbane, Jeffrey S Berns
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1995
The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patientsS Fishbane, R I Lynn
Pageof 36